9-130452214-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_054012.4(ASS1):c.-5-10C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,460,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_054012.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249576Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135130
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460942Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 726704
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: ASS1 c.-5-10C>G is located in the untranslated mRNA region upstream of the initiation codon. Several computational tools predict a significant impact on normal splicing: two predict the variant abolishes a 3 prime acceptor site; one predicts the variant weakens a 3 prime acceptor site; one predicts the variant creates a 3 prime acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 8e-06 in 249576 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.-5-10C>G has been reported in the literature in an individual (compound heterozygote) affected with Citrullinemia Type I (Fernandez-Carmen Diez_2017). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Citrullinemia Uncertain:1
This sequence change falls in intron 2 of the ASS1 gene. It does not directly change the encoded amino acid sequence of the ASS1 protein. This variant is present in population databases (rs375136377, ExAC 0.005%). This variant has been observed in individual(s) with citrullinemia type 1 (PMID: 28111830). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Citrullinemia type I Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at